Susquehanna International Group’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.71M | Sell |
555,000
-1,211,600
| -69% | -$5.14M | ﹤0.01% | 6546 |
|
|
2025
Q4 | $6.38M | Buy |
1,766,600
+80,300
| +5% | +$350K | ﹤0.01% | 3660 |
|
|
2025
Q3 | $6.36M | Buy |
1,686,300
+826,800
| +96% | +$3.19M | ﹤0.01% | 3716 |
|
|
2025
Q2 | $3.33M | Buy |
859,500
+7,900
| +0.9% | +$42.8K | ﹤0.01% | 4752 |
|
|
2025
Q1 | $4.26M | Buy |
851,600
+317,900
| +60% | +$2.01M | ﹤0.01% | 3960 |
|
|
2024
Q4 | $3.85M | Buy |
533,700
+118,100
| +28% | +$902K | ﹤0.01% | 4023 |
|
|
2024
Q3 | $2.55M | Buy |
415,600
+75,400
| +22% | +$511K | ﹤0.01% | 4820 |
|
|
2024
Q2 | $2.26M | Buy |
340,200
+83,400
| +32% | +$615K | ﹤0.01% | 4858 |
|
|
2024
Q1 | $2.61M | Sell |
256,800
-215,800
| -46% | -$2.19M | ﹤0.01% | 4777 |
|
|
2023
Q4 | $5.32M | Buy |
472,600
+386,600
| +450% | +$1.61M | ﹤0.01% | 3609 |
|
|
2023
Q3 | $224K | Buy |
86,000
+7,200
| +9% | +$20.7K | ﹤0.01% | 9993 |
|
|
2023
Q2 | $278K | Buy |
78,800
+7,400
| +10% | +$33.2K | ﹤0.01% | 9598 |
|
|
2023
Q1 | $301K | Sell |
71,400
-89,900
| -56% | -$1.07M | ﹤0.01% | 9709 |
|
|
2022
Q4 | $2.65M | Sell |
161,300
-46,400
| -22% | -$521K | ﹤0.01% | 4206 |
|
|
2022
Q3 | $2.65M | Buy |
207,700
+128,000
| +161% | +$1.89M | ﹤0.01% | 4334 |
|
|
2022
Q2 | $932K | Buy |
79,700
+55,500
| +229% | +$342K | ﹤0.01% | 6699 |
|
|
2022
Q1 | $147K | Sell |
24,200
-39,700
| -62% | -$292K | ﹤0.01% | 11577 |
|
|
2021
Q4 | $585K | Sell |
63,900
-45,000
| -41% | -$478K | ﹤0.01% | 8761 |
|
|
2021
Q3 | $1.23M | Sell |
108,900
-72,300
| -40% | -$879K | ﹤0.01% | 7011 |
|
|
2021
Q2 | $1.78M | Buy |
181,200
+10,800
| +6% | +$148K | ﹤0.01% | 6180 |
|
|
2021
Q1 | $2.41M | Sell |
170,400
-39,600
| -19% | -$640K | ﹤0.01% | 5459 |
|
|
2020
Q4 | $2.37M | Buy |
210,000
+73,000
| +53% | +$860K | ﹤0.01% | 4752 |
|
|
2020
Q3 | $1.81M | Buy |
137,000
+91,100
| +198% | +$1.82M | ﹤0.01% | 4819 |
|
|
2020
Q2 | $492K | Buy |
45,900
+20,400
| +80% | +$112K | ﹤0.01% | 7399 |
|
|
2020
Q1 | $82K | Buy |
+25,500
| New | +$58.6K | ﹤0.01% | 9439 |
|
|
2019
Q4 | – | Sell |
-14,300
| Closed | -$28K | – | 9640 |
|
|
2019
Q3 | $28K | Sell |
14,300
-1,400
| -9% | -$3.1K | ﹤0.01% | 9904 |
|
|
2019
Q2 | $37K | Sell |
15,700
-86,100
| -85% | -$230K | ﹤0.01% | 9904 |
|
|
2019
Q1 | $295K | Buy |
+101,800
| New | +$303K | ﹤0.01% | 7237 |
|
|
2017
Q3 | – | Sell |
-3,713
| Closed | -$356K | – | 8751 |
|
|
2017
Q2 | $356K | Buy |
3,713
+3,209
| +637% | +$533K | ﹤0.01% | 7257 |
|
|
2017
Q1 | $123K | Buy |
+504
| New | +$270K | ﹤0.01% | 8302 |
|
|
2016
Q3 | – | Sell |
-70
| Closed | -$51K | – | 8349 |
|
|
2016
Q2 | $51K | Buy |
+70
| New | +$47.9K | ﹤0.01% | 8232 |
|
Other funds holding ALT
VCM
VPM
N
Susquehanna International Group's ALT Position: Q1 2026 in Review
Susquehanna International Group reduced its Altimmune (ALT) stake by 3.1% in Q1 2026, selling an estimated $183K and leaving 1,325,956 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4621.
Susquehanna International Group first reported a position in ALT in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.7M in Q2 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Susquehanna International Group held 1,325,956 shares of Altimmune worth $4.08M as of Q1 2026.
- Susquehanna International Group sold 43,061 Altimmune shares in Q1 2026, an estimated $183K.
- Altimmune made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4621 holding.
- Susquehanna International Group first reported a position in Altimmune in Q2 2013 and has held it in 38 quarters since.
- Susquehanna International Group's Altimmune position peaked at $14.7M in Q2 2024.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.